JPL Wealth Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.94K Hold
56
– – ﹤0.01% 544
2026
Q2
$9.44K Sell
56
-5
-8% -$742 ﹤0.01% 604
2026
Q1
$8.04K Buy
+61
New +$8.09K ﹤0.01% 574

Other funds holding NBIX

JPL Wealth Management's NBIX Position: Q3 2026 in Review

JPL Wealth Management held its Neurocrine Biosciences (NBIX) position steady in Q3 2026 at 56 shares worth $7.94K. The position accounts for ﹤0.01% of the portfolio, ranked #544.

JPL Wealth Management first reported a position in NBIX in Q1 2026 and has held it in 3 quarters since. The position peaked at $9.44K in Q2 2026. 773 funds tracked by Wall St. Rank hold NBIX as of Q3 2026.

  • JPL Wealth Management held 56 shares of Neurocrine Biosciences worth $7.94K as of Q3 2026.
  • JPL Wealth Management left its Neurocrine Biosciences share count unchanged in Q3 2026.
  • Neurocrine Biosciences made up ﹤0.01% of JPL Wealth Management's portfolio in Q3 2026, its #544 holding.
  • JPL Wealth Management first reported a position in Neurocrine Biosciences in Q1 2026 and has held it in 3 quarters since.
  • JPL Wealth Management's Neurocrine Biosciences position peaked at $9.44K in Q2 2026.
  • 773 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2026.

Based on JPL Wealth Management's 13F filing for Q3 2026, filed 13 Nov 2026.